Alizyme PLC Successful Phase IIb Cetilistat Trial In Obese Diabetics

Alizyme plc (LSE:AZM) is pleased to announce the preliminary results of its successful Phase IIb clinical trial of cetilistat in clinically obese diabetic patients.

MORE ON THIS TOPIC